Cita APA (7a ed.)

Y, K., & C, X. (2018). Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy. Dove Medical Press.

Cita Chicago Style (17a ed.)

Y, Ke, y Xiang C. Transferrin Receptor-targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy. Dove Medical Press, 2018.

Cita MLA (8a ed.)

Y, Ke, y Xiang C. Transferrin Receptor-targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy. Dove Medical Press, 2018.